Yunfeng Shen - Concepedia

Author

Yunfeng Shen

Second Affiliated Hospital of Nanchang University ORCID

Also Known As

Y Shen, Y. Shen, YUNFENG SHEN, Yun-Feng Shen, Yun-feng Shen, YunFeng SHEN, Yunfeng Shen, Yun‐Feng Shen, Yuxue Shen

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Second Affiliated Hospital of Nanchang University Nanchang University Sun Yat-sen University The First Affiliated Hospital, Sun Yat-sen University Third Affiliated Hospital of Sun Yat-sen University

About

Yunfeng Shen is an author at Second Affiliated Hospital of Nanchang University specializing in medicine, cell biology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	809
2	Health Sciences	5	5	512
3	Biochemistry	2	2	270
4	Engineering	1	1	16
5	Natural Sciences	1	1	10

Yunfeng Shen

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001–2018 Qin Zhang, Shucai Xiao, Xiaojuan Jiao, Cardiovascular Diabetology	2023	412
Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis Xuan Xia, Jinhua Yan, Yunfeng Shen, PLoS ONE Liver ResponseInsulin SignalingOxidative StressMetabolic SyndromeGlucose Metabolism	2011	260
Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway Jing Zhang, Lelin Huang, Liu Yang, Aging Acute Lung InjuryHeart FailureApoptosisImmunologyCardiovascular Pharmacology	2020	251
SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis Yunfeng Shen, Lidan Cheng, Minxuan Xu, Metabolism Hepatic Stellate CellsImmunologyPathologyFatty Liver DiseaseInflammation	2023	99
Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression Lidan Cheng, Peng Yu, Fangfang Li, Human Cell Regenerative MedicineMetabolic SyndromeHepatologyMedicineLiver Physiology	2021	71
Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease Ke Fan, Guohui Xue, Xueling Jiang, Cytokine ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver Disease	2020	61
Restoration of intrahepatic regulatory T cells through MMP-9/13-dependent activation of TGF- is critical for immune homeostasis following acute liver injury Lin Lü, Min Feng, Jian Gu, Journal of Molecular Cell Biology	2013	43
Altered DNA methylation of TRIM13 in diabetic nephropathy suppresses mesangial collagen synthesis by promoting ubiquitination of CHOP Yebei Li, Daijin Ren, Yunfeng Shen, EBioMedicine	2020	43
Hydrogen sulfide restores sevoflurane postconditioning mediated cardioprotection in diabetic rats: Role of SIRT1/Nrf2 signaling‐modulated mitochondrial dysfunction and oxidative stress Jing Zhang, Xia Cai, Qin Zhang, Journal of Cellular Physiology	2020	40
Sophocarpine Suppresses NF-κB-Mediated Inflammation Both In Vitro and In Vivo and Inhibits Diabetic Cardiomyopathy Fang Zou, Ling Wang, Han Liu, Frontiers in Pharmacology	2019	33

Page 1